A randomized phase II trial of adjuvant chemotherapy with gemcitabine versus S-1 after major hepatectomy for biliary tract cancer: Kansai Hepato-Biliary Oncology Group (KHBO1208)

被引：0

作者：

Terajima, H. ^{[1
]}

Kobayashi, S. ^{[2
]}

Nagano, H. ^{[3
]}

Tomokuni, A. ^{[4
]}

Gotoh, K. ^{[2
]}

Sakai, D. ^{[5
]}

Hatano, E. ^{[6
]}

Seo, S. ^{[7
]}

Uchida, Y. ^{[1
]}

Ajiki, T. ^{[8
]}

Satake, H. ^{[9
]}

Kamei, K. ^{[10
]}

Tohyama, T. ^{[11
]}

Hirose, T. ^{[12
]}

Ikai, I. ^{[13
]}

Morita, S. ^{[14
]}

Ioka, T. ^{[15
]}

机构：

[1] Kitano Hosp, Tazuke Kofu Kai Med Res Inst, Dept Gastroenterol Surg & Oncol, Osaka, Japan

[2] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka, Japan

[3] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol Breast & Endocrine Surg, Yamaguchi, Japan

[4] Osaka Int Canc Inst, Dept Surg, Osaka, Japan

[5] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Suita, Osaka, Japan

[6] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan

[7] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Japan

[8] Kobe Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg, Dept Surg, Kobe, Hyogo, Japan

[9] Gen Hosp, Kobe City Med Ctr, Dept Med Oncol, Kobe, Hyogo, Japan

[10] Kindai Univ, Fac Med, Dept Surg, Osakasayama, Japan

[11] Ehime Univ, Dept Hepatobiliary Pancreat & Breast Surg, Grad Sch Med, Touon, Japan

[12] Otsu Red Cross Hosp, Dept Surg, Otsu, Shiga, Japan

[13] Natl Hosp Org Kyoto Med Ctr, Dept Surg, Kyoto, Japan

[14] Kyoto Univ, Dept Biomed Stat & Bioinformat, Grad Sch Med, Kyoto, Japan

[15] Osaka Int Canc Inst, Dept Canc Survey & Gatrointestinal Oncol, Osaka, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

762P

引用

页数：1

共 50 条

[41] Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202
Kobayashi, Shogo
Nakachi, Kohei
Ikeda, Masafumi
Konishi, Masaru
Ogawa, Gakuto
Sugiura, Teiichi
Yanagimoto, Hiroaki
Morinaga, Soichiro
Wada, Hiroshi
Shimada, Kazuaki
Takahashi, Yu
Nakagohri, Toshio
Kamata, Ken
Shimizu, Yasuhiro
Ajiki, Tetsuo
Hirano, Satoshi
Gotohda, Naoto
Ueno, Makoto
Okusaka, Takuji
Furuse, Junji
EJSO, 2024, 50 (01):
[42] Feasibility of adjuvant S-1 chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202
Kobayashi, Shogo
Nakachi, Kohei
Ikeda, Masafumi
Konishi, Masaru
Ogawa, Gakuto
Uesaka, Katsuhiko
Yanagimoto, Hiroaki
Morinaga, Soichiro
Wada, Hiroshi
Shimada, Kazuaki
Takahashi, Yu
Nakagohri, Toshio
Gotoh, Kunihito
Kamata, Ken
Shimizu, Yasuhiro
Ajiki, Tetsuo
Kawamoto, Yasuyuki
Ueno, Makoto
Okusaka, Takuji
Furuse, Junji
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[43] Randomized phase II trial of S-1 and cisplatin versus gemeitabine and cisplatin in advanced biliary tract adenocarcinoma
Kang, M.
Lee, J.
Kim, T.
Lee, S.
Park, D.
Seo, D.
Kim, M.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[44] A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer
Chen, Ming-Huang
Chiang, Nai-Jung
Bai, Li-Yuan
Huang, Chien-Jui
Chen, San-Chi
Hsiao, Chin-Fu
Shan, Yan-Shen
Su, Yung-Yeh
Chen, Li-Tzong
ANNALS OF ONCOLOGY, 2022, 33 : S478 - S478
[45] A randomized phase II study of gemcitabine (GEM) plus S-1 combination chemotherapy versus GEM monotherapy in patients (pts) with advanced biliary tract cancer (BTC)
Sasaki, T.
Isayama, H.
Ito, Y.
Yasuda, I.
Toda, N.
Hanada, K.
Matsubara, S.
Maoguchi, H.
Yashlma, Y.
Kamada, H.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
[46] A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer
Kanai, Masashi
Yoshimura, Kenichi
Tsumura, Takehiko
Asada, Masanori
Suzuki, Chihiro
Niimi, Miyuki
Matsumoto, Shigemi
Nishimura, Takafumi
Nitta, Takashi
Yasuchika, Kentaro
Taura, Kojiro
Mori, Yukiko
Hamada, Akihiko
Inoue, Naoya
Tada, Shinsuke
Yanagihara, Kazuhiro
Yazumi, Shujiro
Osaki, Yukio
Chiba, Tsutomu
Ikai, Iwao
Fukushima, Masanori
Uemoto, Shinji
Hatano, Etsuro
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1429 - 1434
[47] A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer
Masashi Kanai
Kenichi Yoshimura
Takehiko Tsumura
Masanori Asada
Chihiro Suzuki
Miyuki Niimi
Shigemi Matsumoto
Takafumi Nishimura
Takashi Nitta
Kentaro Yasuchika
Kojiro Taura
Yukiko Mori
Akihiko Hamada
Naoya Inoue
Shinsuke Tada
Kazuhiro Yanagihara
Shujiro Yazumi
Yukio Osaki
Tsutomu Chiba
Iwao Ikai
Masanori Fukushima
Shinji Uemoto
Etsuro Hatano
Cancer Chemotherapy and Pharmacology, 2011, 67 : 1429 - 1434
[48] PHASE II STUDY OF GEMCITABINE/S-1 COMBINATION THERAPY IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER
Kanai, Masashi
Hatano, Etsuro
Tsumura, Takehiko
Asada, Masanori
Matsumoto, Shigemi
Nishimura, Takafumi
Hamada, Akihiko
Inoue, Naoya
Mori, Yukiko
Yoshimura, Kenichi
Tada, Shinsuke
Yanagihara, Kazuhiro
Yazumi, Shujiro
Osaki, Yukio
Chiba, Tsutomu
ANNALS OF ONCOLOGY, 2010, 21 : 19 - 19
[49] A randomized phase II trial of adjuvant chemotherapy with S-1 versus S-1 and gemcitabine (GS) versus gemcitabine alone (GEM) in patients with resected pancreatic cancer (CAP-002 study).
Yoshitomi, Hideyuki
Shimizu, Hiroaki
Yoshidome, Hiroyuki
Ohtsuka, Masayuki
Kato, Atsushi
Furukawa, Katsunori
Takayashiki, Tsukasa
Kuboki, Satoshi
Okamura, Daiki
Suzuki, Daisuke
Nakajima, Masayuki
Aida, Toshiaki
Miyazaki, Masaru
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[50] Randomized Phase II Study of Gemcitabine plus S-1 Combination Therapy vs. S-1 in Advanced Biliary Tract Cancer: Japan Clinical Oncology Group Study (JCOG0805)
Takashima, Atsuo
Morizane, Chigusa
Ishii, Hiroshi
Nakamura, Kenichi
Fukuda, Haruhiko
Okusaka, Takuji
Furuse, Junji
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (12) : 1189 - 1191

← 1 2 3 4 5 →